Drug intelligence / Profile preview

Qingchang Wenzhong decoction + Mesalazine

Development stage
Unknown
Lead developer
Ethypharm
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Qingchang Wenzhong decoction (QCWZD) is a traditional Chinese medicine prescription composed of several herbs, including Coptis, Cannon ginger, Sophora, Indigo naturalis, Sanguisorba carbon, Aucklandia, Pseudo-Ginseng, and Licorice. Its major active ingredients include berberine hydrochloride, gallic acid, ginsenoside Rg1, ginsenoside Rb1, and liquiritin. Mesalazine is a conventional Western medicine for treating ulcerative colitis (UC). The combination of QCWZD and mesalazine represents an integrated traditional Chinese and Western medicine approach to treating inflammatory bowel diseases, particularly UC. This combination therapy has been shown to accelerate recovery from DSS-induced epithelial injury, reduce mucosal inflammation, attenuate intestinal dysbiosis, enhance tryptophan metabolism, accelerate intestinal stem cells-mediated epithelial regeneration, and protect the integrity of intestinal mucosa through activation of Wnt/β-catenin signals. Clinical studies have shown significant efficacy in patients with mild to moderate ulcerative colitis, providing comprehensive treatment by targeting multiple aspects of UC pathophysiology, especially through alleviating inflammation and intestinal fibrosis.

Other names
QCWZD + Mesalazine
02

Targets

GUCY2C (Guanylate cyclase C receptor)COX15-LOX (Lysyl Oxidase)OCLN (Occludin)

Beyond the preview

Go deeper on Qingchang Wenzhong decoction + Mesalazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingchang Wenzhong decoction + Mesalazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call